Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for postoperative recovery and flap survival in oral cancer flap reconstruction
ChiCTR2300067376Phase 4Not yet recruiting
- Sponsor
- The Affiliated Stomatological Hospital of GuangXi Medical University
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in mouth cancer (2 arms), sponsored by The Affiliated Stomatological Hospital of GuangXi Medical University. Primary endpoints: Flap complications and Quality of life. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
mouth cancer
Beyond the preview
Go deeper on ChiCTR2300067376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300067376.